Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
FormFactor’s ( FORM - Analyst Report ) fourth quarter loss of 32 cents per share was narrower than the Zacks Consensus Estimate of 33 cents loss per share.
Revenues of $47.7 million were up 15.5% sequentially and 57.7% from the year-ago quarter.
Revenues by End User
The system on chip (SoC), DRAM and Flash customers generated 52%, 35% and 13% of fourth quarter revenues, respectively.
The SoC business generated revenues of $24.8 million, up 259.4% sequentially. FormFactor is reaping the benefits of its MicroProbe acquisition, by virtue of which it became the largest supplier of probe cards to the fast growing SoC probe card market. Overall strength in this market is currently being driven by the move from PC applications toward mobile application processors
The DRAM business fell 36.5% sequentially to $16.5 million. The weakness in DRAM probe card demand was on account of oversupply of DRAM devices and corresponding decline in DRAM prices, mainly because of the continued softness in PC demand. FormFactor is also battling lower investment by customers in DRAM test and DRAM probe cards.
We believe that the DRAM market may recover as the industry undergoes a structural shift from PC centered computing to mobile and cloud centered computing.
The Flash business was down 23.8% sequentially to $6.4 million. NAND revenue declined 30.2% to $3.7 million, while NOR revenue dropped 12.9% to $2.7 million in the fourth quarter .
Margins
The GAAP gross margin decreased 2,635 basis points (bps) sequentially but rose 986 bps year over year to (6.6%). Lower fixed cost leverage despite the benefit from restructuring actions in the third quarter was the reason for the sequential decline. However, the contribution from Microprobe was an offsetting factor in the last quarter.
Total operating expenses of $21.9 million were down 4.1% sequentially and 5.2% from the year-ago quarter. The operating margin was (52.5%), down 1,700 bps sequentially but up 4031 bps from the year-ago quarter. R&D as a percentage of sales was flat sequentially and down from last year. While SG&A also declined from last year, it increased sequentially.
Net Income
The pro forma net loss was $16.9 million or 35.4% of sales, compared to a loss of $10.7 million or 25.9% in the previous quarter and a loss of $26.6 million or 87.9% in the year-ago quarter.
Including restructuring charges and impairment of long-lived assets on a tax-adjusted basis, the GAAP net income per share came to $0.01 in the last quarter compared to a loss of 29 cents in the prior quarter and 54 cents in the year-ago quarter.
Balance Sheet
Inventories of $23.6 million were up 17.8% in the fourth quarter of 2012. The company ended with cash and marketable securities of $165.8 million, down $110.4 million during the quarter. FormFactor has no debt. Long-term liabilities totaled $11.4 million at quarter-end.
Cash used from operations was $110.4 in the fourth quarter million compared with $1.6 million in the prior quarter.
Guidance
For the first quarter, FormFactor expects revenue of $48.0−$53.0 million. The non-GAAP gross margin is expected to be in the range of 17%–21%. Non-GAAP operating expenses are expected to be $21.0–$22.0 million. The cash burn in the quarter is expected to be $10.0–$12.0 million, excluding stock repurchase.
Our Recommendation
FormFactor is an original equipment manufacturer (OEM) of automated wafer probe cards that are used in the back-end portion of the semiconductor integrated circuits (ICs) manufacturing process. It is a well-positioned player in the semiconductor industry and has further solidified its position with the addition of MicroProbe’s SoC probe card segment. The acquisition will make FormFactor a bigger player in the SoC probe card market.
However, the lingering macroeconomic weakness and softness in the PC market that impacted FormFactor’s results in the last quarter are expected to continue in the next. Therefore, FormFactor’s core business (probe cards for DRAM and Flash) is likely to remain under pressure in the near term.
FormFactor shares carry a Zacks Rank #3 (Hold). Other front-end equipment suppliers such as Diodes Inc. ( DIOD - Snapshot Report ) , Advanced Semiconductor Engineering Inc. ( ASX - Snapshot Report ) and PLX Technology Inc. ( PLXT ) all have a Zacks Rank #1 (Strong Buy).
Read the full Analyst Report on FORM
Read the full Snapshot Report on DIOD
Read the full on PLXT
Read the full Snapshot Report on ASX